Mitchell E J, Fitz-Gibbon L, O'Connor-McCourt M D
Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec.
J Cell Physiol. 1992 Feb;150(2):334-43. doi: 10.1002/jcp.1041500217.
Transforming growth factor-beta is likely to be an important factor controlling placental activities, including growth, differentiation, invasiveness, hormone production, and immunosuppression. We have used a chemical cross-linking technique with either 125I-TGF-beta 1 or 125I-TGF-beta 2 and bis(sulfosuccinimidyl) suberate (BS3) to characterize TGF-beta binding components on human placental cells in primary culture. Trophoblast-enriched primary cultures exhibited a predominant affinity-labelled complex characteristic of membrane-anchored betaglycan (formerly termed the Type III TGF-beta receptor) and relatively low levels of the Type I and Type II TGF-beta receptor complexes. The results from affinity labelling saturation and competition experiments with TGF-beta 1 and TGF-beta 2 suggest the existence of two distinct subtypes of betaglycan: one subtype has a lower capacity and higher affinity, binds both TGF-beta 1 and TGF-beta 2, yet has a preferential affinity for TGF-beta 2; the second subtype has a higher capacity and lower affinity and binds TGF-beta 1 exclusively. In contrast, mesenchymal cell-enriched placental primary cultures possessed only one subtype of the betaglycan component that binds the two TGF-beta isoforms with similar affinities and capacities as observed on most cell lines. These experiments demonstrate that the betaglycan component which exhibits a higher affinity for TGF-beta 2 than for TGF-beta 1, that we had observed previously on term placental membranes, is actually present on trophoblast cells. In addition to the two distinctive betaglycan subtypes, subtypes of the Type I and II TGF-beta receptors were detected on the trophoblast-enriched cultures. In competition experiments, when 125I-TGF-beta 1 was used as the radiotracer, the Type I and II TGF-beta receptors show a much higher affinity for TGF-beta 1 than for TGF-beta 2, as observed with other cell types. However, when 125I-TGF-beta 2 was used, low abundance subtypes of both the Type I and II receptors that show similar affinities for TGF-beta 1 and TGF-beta 2 were also revealed.
转化生长因子-β可能是控制胎盘活动的重要因素,这些活动包括生长、分化、侵袭、激素产生和免疫抑制。我们使用化学交联技术,用125I-TGF-β1或125I-TGF-β2与双(磺基琥珀酰亚胺)辛二酸酯(BS3)来表征原代培养的人胎盘细胞上的TGF-β结合成分。富含滋养层细胞的原代培养物表现出膜锚定的β聚糖(以前称为III型TGF-β受体)的主要亲和标记复合物特征,以及相对较低水平的I型和II型TGF-β受体复合物。用TGF-β1和TGF-β2进行亲和标记饱和及竞争实验的结果表明,β聚糖存在两种不同的亚型:一种亚型容量较低但亲和力较高,能结合TGF-β1和TGF-β2,但对TGF-β2有优先亲和力;第二种亚型容量较高但亲和力较低,且仅结合TGF-β1。相比之下,富含间充质细胞的胎盘原代培养物仅拥有一种β聚糖成分亚型,其结合两种TGF-β异构体的亲和力和容量与大多数细胞系上观察到的相似。这些实验表明,我们之前在足月胎盘膜上观察到的对TGF-β2比对TGF-β1具有更高亲和力的β聚糖成分实际上存在于滋养层细胞上。除了两种不同的β聚糖亚型外,在富含滋养层细胞的培养物中还检测到了I型和II型TGF-β受体的亚型。在竞争实验中,当使用125I-TGF-β1作为放射性示踪剂时,I型和II型TGF-β受体对TGF-β1的亲和力比对TGF-β2高得多,这与其他细胞类型中观察到的情况相同。然而,当使用125I-TGF-β2时,还发现了I型和II型受体的低丰度亚型,它们对TGF-β1和TGF-β2的亲和力相似。